KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,093,000 | +54550.0% | 78,083 | +66637.6% | 0.00% | – |
Q2 2021 | $2,000 | -99.6% | 117 | -99.4% | 0.00% | -100.0% |
Q1 2021 | $529,000 | -94.1% | 18,717 | -93.2% | 0.00% | -94.4% |
Q4 2020 | $8,966,000 | +5.4% | 274,512 | -1.1% | 0.02% | -10.0% |
Q3 2020 | $8,504,000 | +169980.0% | 277,561 | +98676.2% | 0.02% | – |
Q2 2020 | $5,000 | +400.0% | 281 | +226.7% | 0.00% | – |
Q1 2020 | $1,000 | -99.7% | 86 | -99.7% | 0.00% | -100.0% |
Q4 2019 | $346,000 | -89.6% | 25,128 | -88.6% | 0.00% | -87.5% |
Q3 2019 | $3,330,000 | +6985.1% | 219,490 | +9015.0% | 0.01% | – |
Q2 2019 | $47,000 | +1466.7% | 2,408 | +1386.4% | 0.00% | – |
Q1 2019 | $3,000 | +50.0% | 162 | -8.0% | 0.00% | – |
Q4 2018 | $2,000 | +100.0% | 176 | +282.6% | 0.00% | – |
Q3 2018 | $1,000 | -99.5% | 46 | -99.6% | 0.00% | -100.0% |
Q2 2018 | $206,000 | -17.9% | 11,309 | -15.5% | 0.00% | 0.0% |
Q1 2018 | $251,000 | +24.9% | 13,391 | +2.0% | 0.00% | 0.0% |
Q4 2017 | $201,000 | – | 13,122 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |